Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-05

Clinical Trial Update: Hesperidin RCT in MS [NA]

View source ↗

Summary

A clinical trial evaluating hesperidin for multiple sclerosis is currently recruiting in the UK. The study is sponsored by Swansea University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hesperidin (Hesperidin)

Snippet

Sponsor: Swansea University | Conditions: Multiple Sclerosis | NA | Status: RECRUITING